{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:06:20Z","timestamp":1794873980432,"version":"4.9.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023731","name":"Regional Government of Andalusia Ministry of Health and Consumer Affairs","doi-asserted-by":"publisher","award":["PI-0094\\u20132020"],"award-info":[{"award-number":["PI-0094\\u20132020"]}],"id":[{"id":"10.13039\/501100023731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["847468"],"award-info":[{"award-number":["847468"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PRE2020\\u2013094225"],"award-info":[{"award-number":["PRE2020\\u2013094225"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["BIO-0139"],"award-info":[{"award-number":["BIO-0139"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012514","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red-Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012514","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022\\u20131381850B-I00"],"award-info":[{"award-number":["PID2022\\u20131381850B-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI22\/01769"],"award-info":[{"award-number":["PI22\/01769"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016145","name":"Ministerio de Sanidad, Consumo y Bienestar Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003751","name":"Ministerio de Sanidad, Servicios Sociales e Igualdad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biopha.2025.118330","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T09:23:33Z","timestamp":1751707413000},"page":"118330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["miR-191\u20135p: A tumour suppressor miRNA and a personalized biomarker and potential therapeutic tool connecting prostate cancer and obesity"],"prefix":"10.1016","volume":"189","author":[{"given":"Francisco","family":"Porcel-Pastrana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Montero-Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Herrero-Aguayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5909-3553","authenticated-orcid":false,"given":"Prudencio","family":"S\u00e1ez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1785-9797","authenticated-orcid":false,"given":"Jes\u00fas M.","family":"Perez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1204-0371","authenticated-orcid":false,"given":"Andr\u00e9","family":"Sarmento-Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Campos-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3495-5705","authenticated-orcid":false,"given":"Oriol A.","family":"Rangel-Zu\u00f1iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Carrasco-Valiente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Mart\u00ednez-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4578-2179","authenticated-orcid":false,"given":"Manuel D.","family":"Gahete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"G\u00f3mez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-1913","authenticated-orcid":false,"given":"Ra\u00fal M.","family":"Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118330_bib1","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118330_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer\u20142020 Update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2025.118330_bib3","doi-asserted-by":"crossref","DOI":"10.1159\/000474493","article-title":"Free\/total prostate-specific antigen ratio - hope and controversies","volume":"31","author":"Ravery","year":"1997","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2025.118330_bib4","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/ijcp.12883","article-title":"Clarifying the PSA grey zone: the management of patients with a borderline PSA","author":"Ross","year":"2016","journal-title":"Int J. Clin. Pr."},{"key":"10.1016\/j.biopha.2025.118330_bib5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jmri.28505","article-title":"Patients with \u201cGray Zone\u201d PSA levels: application of prostate MRI and MRS in the diagnosis of prostate cancer","volume":"57","author":"Li","year":"2023","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.biopha.2025.118330_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41416-024-02934-x","article-title":"The accuracy of Fluorine 18-labelled prostate-specific membrane antigen PET\/CT and MRI for diagnosis of prostate cancer in PSA Grey Zone","volume":"132","author":"Luo","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118330_bib7","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.298.19.2275","article-title":"Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer","volume":"298","author":"Ba\u00f1ez","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2025.118330_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2018.3712","article-title":"Prostate-specific antigen-based screening for prostate cancer evidence report and systematic review for the us preventive services task force","volume":"319","author":"Fenton","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2025.118330_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2025.118330_bib10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1517\/14728222.11.8.1119","article-title":"MicroRNAs as therapeutic targets in human diseases","volume":"11","author":"Jeyaseelan","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2025.118330_bib11","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1007\/s12035-016-0213-8","article-title":"Circular RNAs: the emerging class of non-coding RNAs and their potential role in human neurodegenerative diseases","volume":"54","author":"Kumar","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118330_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of MicroRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.biopha.2025.118330_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/10409238.2012.738643","article-title":"MicroRNA biogenesis: regulating the regulators","volume":"48","author":"Finnegan","year":"2013","journal-title":"Crit. Rev. Biochem Mol. Biol."},{"key":"10.1016\/j.biopha.2025.118330_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/cdd.2014.112","article-title":"The complexity of MiRNA-mediated repression","volume":"22","author":"Wilczynska","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2025.118330_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1042\/BST20150157","article-title":"Mechanisms of regulation of mature MiRNAs","volume":"43","author":"Towler","year":"2015","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.biopha.2025.118330_bib16","doi-asserted-by":"crossref","first-page":"19030","DOI":"10.3390\/molecules201019030","article-title":"MiRNA stability in frozen plasma samples","volume":"20","author":"Balzano","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118330_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ymeth.2007.10.008","article-title":"In situ detection of precursor and mature MicroRNAs in paraffin embedded, formalin fixed tissues and cell preparations","volume":"44","author":"Nuovo","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2025.118330_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific MicroRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.biopha.2025.118330_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2019-320282","article-title":"Liquid biopsy in the clinical management of hepatocellular carcinoma","volume":"69","author":"Von Felden","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2025.118330_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-0856-1_6","article-title":"Use of serum-circulating MiRNA profiling for the identification of breast cancer biomarkers","volume":"1165","author":"Mar-Aguilar","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2025.118330_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2014.00099","article-title":"MiR-191: an emerging player in disease biology","volume":"5","author":"Nagpal","year":"2014","journal-title":"Front Genet"},{"key":"10.1016\/j.biopha.2025.118330_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-62703-083-0_24","article-title":"Salivary MicroRNAs and oral cancer detection","author":"Yoshizawa","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2025.118330_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2022.02.010","article-title":"Dysregulation of the MiRNome unveils a crosstalk between obesity and prostate cancer: MiR-107 asa personalized diagnostic and therapeutic tool","volume":"27","author":"Herrero-Aguayo","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2025.118330_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2014.07.035","article-title":"Exosomal MiR-1290 and MiR-375 as prognostic markers in castration-resistant prostate cancer","volume":"67","author":"Huang","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2025.118330_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.eururo.2015.12.054","article-title":"The potential of MicroRNAs as prostate cancer biomarkers","volume":"70","author":"Fabris","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2025.118330_bib26","first-page":"3","article-title":"Identification of thyroid-associated serum MicroRNA profiles and their potential use in thyroid cancer follow-up","volume":"1","author":"Rosignolo","year":"2017","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.biopha.2025.118330_bib27","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.7150\/jca.29293","article-title":"Clinical significance of MicroRNA-196b-5p in hepatocellular carcinoma and its potential molecular mechanism","volume":"10","author":"Zhang","year":"2019","journal-title":"J. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2025.118330_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0510565103","article-title":"A MicroRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.biopha.2025.118330_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108989","article-title":"Identification of MiRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer","volume":"180","author":"Xu","year":"2024","journal-title":"Comput. Biol. Med"},{"key":"10.1016\/j.biopha.2025.118330_bib30","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.biopha.2025.118330_bib31","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.3390\/jcm8122056","article-title":"Clinical Medicine Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer","volume":"8","author":"Jim\u00e9nez-Vacas","year":"2019","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2025.118330_bib32","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/jcmm.13994","article-title":"Clinical association of metabolic syndrome, C-reactive protein and testosterone levels with clinically significant prostate cancer","volume":"23","author":"G\u00f3mez-G\u00f3mez","year":"2019","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2025.118330_bib33","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1210\/clinem\/dgaa580","article-title":"Influence of obesity in the MiRNome: MiR-4454, a key regulator of insulin response via splicing modulation in prostate","volume":"106","author":"Herrero-Aguayo","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118330_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado8231","article-title":"SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer","volume":"10","author":"Montero-Hidalgo","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2025.118330_bib35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 Years of Image Analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2025.118330_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective MicroRNA target sites in mammalian MRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.biopha.2025.118330_bib37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial MicroRNA Target Predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2025.118330_bib38","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"MiRDB: an online database for prediction of functional MicroRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2025.118330_bib39","doi-asserted-by":"crossref","first-page":"D1139","DOI":"10.1093\/nar\/gkab784","article-title":"CancerMIRNome: an interactive analysis and visualization database for MiRNome profiles of human cancer","volume":"50","author":"Li","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2025.118330_bib40","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2025.118330_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.biopha.2025.118330_bib42","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-18-2849","article-title":"Large-scale circulating MicroRNA profiling for the liquid biopsy of prostate cancer","volume":"25","author":"Urabe","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118330_bib43","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: weighing the evidence","volume":"63","author":"Allott","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2025.118330_bib44","first-page":"12","article-title":"Cancer Statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118330_bib45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/23808993.2020.1804866","article-title":"Noninvasive biomarkers to guide intervention: toward personalized patient management in prostate cancer","volume":"5","author":"Frantzi","year":"2020","journal-title":"Expert Rev. Precis Med Drug Dev."},{"key":"10.1016\/j.biopha.2025.118330_bib46","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12916-021-02230-y","article-title":"Systematic Review and Meta-Analysis of the Diagnostic Accuracy of Prostate-Specific Antigen (PSA) for the Detection of Prostate Cancer in Symptomatic Patients","volume":"20","author":"Merriel","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.biopha.2025.118330_bib47","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2011.11.013","article-title":"The correlation between metabolic syndrome and prostatic diseases","volume":"61","author":"De Nunzio","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2025.118330_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.biocel.2018.07.003","article-title":"S. Roles of MicroRNA in prostate cancer cell metabolism","volume":"102","author":"Kasomva","year":"2018","journal-title":"Int J. Biochem Cell Biol."},{"key":"10.1016\/j.biopha.2025.118330_bib49","doi-asserted-by":"crossref","first-page":"28943","DOI":"10.3390\/ijms161226138","article-title":"Non-coding RNAs in castration-resistant prostate cancer: regulation of androgen receptor signaling and cancer metabolism","volume":"16","author":"Shih","year":"2015","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118330_bib50","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.2147\/CMAR.S257441","article-title":"Circ-ZNF609 accelerates the radioresistance of prostate cancer cells by promoting the glycolytic metabolism through MiR-501-3p\/HK2 axis","volume":"12","author":"Du","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.biopha.2025.118330_bib51","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s11154-023-09838-w","article-title":"Exploring the role of the inflammasomes on prostate cancer: interplay with obesity","volume":"24","author":"P\u00e9rez-G\u00f3mez","year":"2023","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.biopha.2025.118330_bib52","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41585-023-00764-9","article-title":"Obesity and prostate cancer \u2014 microenvironmental roles of adipose tissue","volume":"20","author":"Saha","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.biopha.2025.118330_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103543","article-title":"Obesity and prostate cancer: a narrative review","volume":"169","author":"Wilson","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biopha.2025.118330_bib54","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1530\/EJE-21-0552","article-title":"Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma MiRNA profiling","volume":"185","author":"Romero-Ruiz","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118330_bib55","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0026-0495(97)90191-8","article-title":"Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients","volume":"46","author":"Villa","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2025.118330_bib56","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/aja.2012.160","article-title":"MiR-21, MiR-221 and MiR-222 expression and prostate cancer recurrence among obese and non-obese cases","volume":"15","author":"Amankwah","year":"2013","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.biopha.2025.118330_bib57","first-page":"1686","article-title":"MicroRNA-191-5p exerts a tumor suppressive role in renal cell carcinoma","volume":"15","author":"Chen","year":"2018","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.biopha.2025.118330_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/cells13131099","article-title":"Comparative assessment of MiR-185-5p and MiR-191-5p expression: from normal endometrium to high-grade endometrial cancer","author":"Oropeza-de Lara","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118330_bib59","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1261\/rna.060657.117","article-title":"P53-MiR-191-SOX4 regulatory loop affects apoptosis in breast cancer","volume":"23","author":"Sharma","year":"2017","journal-title":"RNA"},{"key":"10.1016\/j.biopha.2025.118330_bib60","first-page":"3689","article-title":"MiRNA-191-5p Represses Cell Growth by Targeting CDK6 in Gastric Cancer","volume":"100","author":"Cao","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.biopha.2025.118330_bib61","doi-asserted-by":"crossref","DOI":"10.1177\/2058738418790318","article-title":"Upregulation of PD-L1 Predicts Poor Prognosis and Is Associated with MiR-191-5p Dysregulation in Colon Adenocarcinoma","volume":"32","author":"Chen","year":"2018","journal-title":"Int J. Immunopathol. Pharm."},{"key":"10.1016\/j.biopha.2025.118330_bib62","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1080\/21655979.2021.1918991","article-title":"Long non-coding RNA XIST promotes retinoblastoma cell proliferation, migration, and invasion by modulating MicroRNA-191-5p\/brain derived neurotrophic factor","volume":"12","author":"Xu","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.biopha.2025.118330_bib63","doi-asserted-by":"crossref","first-page":"E1915","DOI":"10.1210\/jc.2011-0408","article-title":"MiR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting","volume":"96","author":"Colamaio","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118330_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/92dfa670-d431-4d68-b70b-706df1f93e46","article-title":"Estrogen mediated-activation of MiR-191\/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status","volume":"9","author":"Di Leva","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.biopha.2025.118330_bib65","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/carcin\/bgt107","article-title":"MicroRNA-191, an estrogen-responsive MicroRNA, functions as an oncogenic regulator in human breast cancer","volume":"34","author":"Nagpal","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2025.118330_bib66","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1158\/0008-5472.CAN-10-1313","article-title":"Hsa-MiR-191 is a candidate oncogene target for hepatocellular carcinoma therapy","volume":"70","author":"Elyakim","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118330_bib67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/cm.21031","article-title":"Tropomodulins: pointed-end capping proteins that regulate actin filament architecture in diverse cell types","volume":"69","author":"Yamashiro","year":"2012","journal-title":"Cytoskeleton"},{"key":"10.1016\/j.biopha.2025.118330_bib68","doi-asserted-by":"crossref","first-page":"486","DOI":"10.7150\/jca.100556","article-title":"MicroRNA MTCO3P38 inhibits the TMOD1\/MMP13 pathway to alleviate the progression of hepatocellular carcinoma","volume":"16","author":"Wu","year":"2025","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2025.118330_bib69","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/carcin\/bgab121","article-title":"MiR-145 modulates the radiosensitivity of non-small cell lung cancer cells by suppression of TMOD3","volume":"43","author":"Li","year":"2022","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2025.118330_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108588","article-title":"MicroRNA-885 regulates the growth and epithelial mesenchymal transition of human liver cancer cells by suppressing tropomodulin 1 expression","volume":"693","author":"Feng","year":"2020","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.biopha.2025.118330_bib71","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2020.11956","article-title":"MicroRNA-490-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells via targeting TMOD3","volume":"20","author":"Wang","year":"2020","journal-title":"Oncol. Lett."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T11:58:29Z","timestamp":1754654309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225005244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":71,"alternative-id":["S0753332225005244"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118330","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-191\u20135p: A tumour suppressor miRNA and a personalized biomarker and potential therapeutic tool connecting prostate cancer and obesity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118330"}}